000869:SZSEYantai Changyu Pioneer Wine Company Limited Analysis
Data as of 2026-06-22 - not real-time
CN¥16.70
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Yantai Changyu’s stock is trading at CNY 16.7, sitting just above the computed support of CNY 16.31 and well below its 20‑day SMA of CNY 17.71. The 14‑day RSI of 26.9 and a bearish MACD histogram signal a continued short‑term downtrend. Volume has been tapering, reinforcing the bearish momentum. Despite the weak technical picture, the discounted cash‑flow model places fair value at CNY 18.04, implying a modest upside of roughly 8 %. The forward price‑to‑earnings ratio of 17.8 further supports a potential re‑rating. The “Extreme Greed” sentiment index at 91.46 suggests market optimism may be overstated for this stock.
Fundamentally, revenue grew 8.3 % YoY and gross margin stays healthy at 54.7 %, but net profit margin is only 1.98 % and ROE languishes at 0.57 %. The company holds ample cash (CNY 2.07 bn) against modest debt (CNY 0.42 bn), yielding a net‑cash position that comfortably funds its 1.5 % dividend. The payout ratio sits at just 4 %, indicating strong dividend sustainability. Low beta (0.23) and defensive consumer‑staple positioning temper market volatility, though recent price swings have produced a 30‑day volatility of nearly 20 % and a max drawdown of 26 %. Geographic concentration in China adds medium‑level exposure to domestic economic cycles, while regulatory and currency risks remain moderate. Overall, the stock appears undervalued on a value basis, but the weak earnings profile and bearish technicals advise caution in the near term.
Fundamentally, revenue grew 8.3 % YoY and gross margin stays healthy at 54.7 %, but net profit margin is only 1.98 % and ROE languishes at 0.57 %. The company holds ample cash (CNY 2.07 bn) against modest debt (CNY 0.42 bn), yielding a net‑cash position that comfortably funds its 1.5 % dividend. The payout ratio sits at just 4 %, indicating strong dividend sustainability. Low beta (0.23) and defensive consumer‑staple positioning temper market volatility, though recent price swings have produced a 30‑day volatility of nearly 20 % and a max drawdown of 26 %. Geographic concentration in China adds medium‑level exposure to domestic economic cycles, while regulatory and currency risks remain moderate. Overall, the stock appears undervalued on a value basis, but the weak earnings profile and bearish technicals advise caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near support
- bearish RSI and MACD
- decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside to fair value
- forward PE ~18 indicating cheapness
- strong cash position supporting dividend
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- low beta and defensive sector reduce volatility
- sustainable dividend payout
- weak ROE limiting long‑term growth
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin1.98%
P/E Ratio167.0
ROE0.57%
ROA0.59%
Debt/Equity3.99
P/B Ratio1.1
Op. Cash FlowCN¥518.4M
Free Cash FlowCN¥545.2M
Technical Analysis
TrendBearish
RSI26.9
SupportCN¥16.31
ResistanceCN¥18.85
MA 20CN¥17.71
MA 50CN¥18.59
MA 200CN¥20.44
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair ValueCN¥18.04
GradeUndervalued
TypeValue
Dividend Yield1.50%
Risk Assessment
Beta0.23
Volatility19.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.